WuXi Biologics (Cayman) (HKSE:02269) Cash per Share : HK$2.47 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). WuXi Biologics (Cayman)'s Cash per Share for the quarter that ended in Jun. 2024 was HK$2.47.

WuXi Biologics (Cayman) Cash per Share Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Cash per Share Chart

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

1.93

2.46

3.20

2.30

2.89

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash per Share	Get a 7-Day Free Trial														2.71	2.30	2.24	2.89	2.47

WuXi Biologics (Cayman) Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

WuXi Biologics (Cayman)'s Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	12297.834	/	4,258
	=	2.89

WuXi Biologics (Cayman)'s Cash per Share for the quarter that ended in Jun. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	10258.042	/	4,153
	=	2.47

WuXi Biologics (Cayman) (HKSE:02269) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

WuXi Biologics (Cayman) Cash per Share Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (HKSE:02269) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 1FW2:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 17 billion. North America represented 47.4% of total revenue in 2023. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Li Ge	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Brown Brothers Harriman & Co.	2502 Approved lending agent
Zhao Ning	2202 Interest of your spouse
Liu Xiaozhong	2401 A concert party to an agreement to buy shares
New Wuxi Life Science Holdings Limited	2201 Interest of corporation controlled by you
New Wuxi Life Science Limited	2201 Interest of corporation controlled by you
Wuxi Biologics Holdings Limited	2101 Beneficial owner
Wuxi Pharmatech (cayman) Inc.	2201 Interest of corporation controlled by you
Zhang Zhaohui	2401 A concert party to an agreement to buy shares
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you

WuXi Biologics (Cayman) Headlines

No Headlines